Inflammatory arthritis cohort studies reporting sex-stratified pain scores.
| Study | Type of Arthritis | Women; Men, n | Female HAQ Score | Male HAQ Score | Female DAS28 Score | Male DAS28 Score | Pain Measure | |
|---|---|---|---|---|---|---|---|---|
| Furst 201014 | USA (CORRONA) | RA | 4166; 1438 | 0.38 (mHAQ) | 0.32 | NR | NR | VAS (mean) |
| Sokka 200941 | Various (QUEST-RA) | RA | 4755; 1249 | 1.09 | 0.76 | 4.30 | 3.76 | VAS (mean) |
| Wallenius 200918 | Norway | RA | 372; 102 | 0.67 (mHAQ) | 0.59 | 4.7 | 4.2 | VAS (mean) |
| Wallenius 200918 | Norway | RA | 372; 102 | 0.67 (mHAQ) | 0.59 | 4.7 | 4.2 | SF-36 BP (mean) |
| Wallenius 200927 | Norway | PsA | 102; 169 | VAS, SF-36 BP (mean) | ||||
| Castrejon 200928 | Leiden | RA | 160; 57 | 1.18 | 0.99 | NR | NR | VAS (mean) |
| Castrejon 200928 | Madrid | RA | 150; 45 | 1.17 | 0.75 | 4.71 | 3.76 | VAS (mean) |
| Jawaheer 200942 | USA (RADIUS-1) | RA | 3327; 1032 | 1.36 | 1.08 | NR | NR | VAS (mean) |
| Jawaheer 200942 | USA (RADIUS-2) | RA | 3357; 1066 | 1.42 | 1.11 | NR | NR | VAS (mean) |
| Jawaheer 200943 | Denmark (DANBIO) | RA | 1852; 656 | 1.4 (HAQ-DI) | 1.0 (HAQ-DI) | 5.1 (CRP) | 5.1 (CRP) | VAS (mean) |
| West 200919 | Sweden | RA | 34; 17 | NR | NR | NR | NR | SF-36 BP (mean) |
| Iikuni 200922 | Japan (IORRA) | RA | 4027; 796 | NR | NR | NR | NR | VAS (median) |
| Rodrigues 200924 | Portugal | RA | NR | NR | NR | NR | VAS, SF-36 BP (coefficient) | |
| Ursum 200844 | Netherlands | RA | 466; 214 | 1.30 | 1.09 | 5.32 | 4.98 | VAS (mean) |
| Jawaheer 200829 | USA (Western Consortium of Practicing Rheumatologists) | RA | 223; 68 | 1.27 | 0.91 | NR | NR | VAS (mean) |
| Kristensen 200845 | Sweden (SSATG) | RA | 1212; 353 | 1.42 | 1.12 | 5.62 | 5.36 | VAS (mean) |
| Forslind 200713 | Sweden (BARFOT) | RA | 446; 252 | 1.11 | 0.83 | 5.37 | 5.09 | VAS (mean) |
| Leeb 200746 | Austria | RA | 432; 125 | NR | NR | 3.66 | 3.01 | VAS (mean) |
| Uhlig 200747 | Norway (ORAR) | RA | 812; 212 | NR | NR | NR | NR | SF-36 BP (mean) |
| Odegard 200723 | Norway (EURIDISS) | RA | NR | NR | NR | NR | NR | VAS, AIMS (coefficient) |
| Hakkinen 200648 | Finland | RA | 100; 35 | NR | NR | NR | NR | VAS (mean) |
| Hallert 200311 | Sweden (TIRA) | RA | 196; 88 | NR | NR | NR | NR | VAS (change in mean) |
| Ramjeet 200525 | England | IP | 76; 36 | 0.97 | 0.78 | NR | NR | VAS (mean) |
| Affleck 199920 | USA | RA | 58; 18 | NR | NR | NR | NR | RADAS (mean) |
| Katz 199649 | USA | RA | 531; 157 | 1.30 | 0.88 | NR | NR | Verbal scale 0–100 (mean) |
| Barlow 199326 | England | AS | 48; 129 | NR | NR | NR | NR | VAS (mean) |
| Thompson 199150 | England | RA | 63; 22 | 1.7 | 1.1 | NR | NR | VAS (mean) |
AIMS: Arthritis Impact Measurement Scale; AS: ankylosing spondylitis; CRP: C-reactive protein; HAQ: Health Assessment Questionnaire; HAQ-DI: Health Assessment Questionnaire-Disability Index; IP: inflammatory polyarthritis; mHAQ: modified Health Assessment Questionnaire; NR: not reported; PsA: psoriatic arthritis; RA: rheumatoid arthritis; RADAS: Rheumatoid Arthritis Disease Activity Score; SF-36 BP: Bodily Pain component of the Medical Outcomes Study Short Form-36; VAS: visual analog scale.